{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:24:31Z","timestamp":1784035471684,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10067-025-07683-7","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T02:13:45Z","timestamp":1761272025000},"page":"4895-4907","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["ANAs and triple positivity effect on disease activity and sustained remission in rheumatoid arthritis: a retrospective real-world machine learning approach"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1649-5290","authenticated-orcid":false,"given":"Kevin","family":"Maldonado-Ca\u00f1\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9513-4700","authenticated-orcid":false,"given":"Paola","family":"Coral-Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6111-902X","authenticated-orcid":false,"given":"Paul","family":"M\u00e9ndez-Patarroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0684-9542","authenticated-orcid":false,"given":"Wilson","family":"Bautista-Molano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2734-7210","authenticated-orcid":false,"given":"Gerardo","family":"Quintana-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"issue":"1","key":"7683_CR1","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","volume":"4","author":"JS Smolen","year":"2018","unstructured":"Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS et al (2018) Rheumatoid arthritis. Nat Rev Dis Primers 4(1):18001","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"7683_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s42358-025-00437-8","volume":"65","author":"K Maldonado-Ca\u00f1\u00f3n","year":"2025","unstructured":"Maldonado-Ca\u00f1\u00f3n K, Buitrago G, Quintana-L\u00f3pez G (2025) Prevalence, comorbidities, and disease-related complications of rheumatoid arthritis in Colombia: a national cross-sectional study based on administrative claims data. Adv Rheumatol 65(1):6","journal-title":"Adv Rheumatol"},{"issue":"1","key":"7683_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/rheumatology\/ker250","volume":"51","author":"K Jayakumar","year":"2012","unstructured":"Jayakumar K, Norton S, Dixey J, James D, Gough A, Williams P et al (2012) Sustained clinical remission in rheumatoid arthritis: prevalence and prognostic factors in an inception cohort of patients treated with conventional DMARDS. Rheumatology 51(1):169\u2013175","journal-title":"Rheumatology"},{"issue":"2","key":"7683_CR4","doi-asserted-by":"publisher","first-page":"e000946","DOI":"10.1136\/rmdopen-2019-000946","volume":"5","author":"A Boman","year":"2019","unstructured":"Boman A, Brink M, Lundquist A, Hansson M, Mathsson-Alm L, R\u00f6nnelid J et al (2019) Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study. RMD Open 5(2):e000946","journal-title":"RMD Open"},{"issue":"9","key":"7683_CR5","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1007\/s10067-019-04554-w","volume":"38","author":"YB Joo","year":"2019","unstructured":"Joo YB, Park YJ, Park KS, Kim KJ (2019) Association of cumulative anti-cyclic citrullinated protein antibodies with radiographic progression in patients with rheumatoid arthritis. Clin Rheumatol 38(9):2423\u20132432","journal-title":"Clin Rheumatol"},{"issue":"12","key":"7683_CR6","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1002\/art.40237","volume":"69","author":"M Truchetet","year":"2017","unstructured":"Truchetet M, Dublanc S, Barnetche T, Vittecoq O, Mariette X, Richez C et al (2017) Association of the presence of anti\u2013carbamylated protein antibodies in early arthritis with a poorer clinical and radiologic outcome. Arthritis Rheumatol 69(12):2292\u20132302","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"7683_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1136\/annrheumdis-2015-208870","volume":"76","author":"S Ajeganova","year":"2017","unstructured":"Ajeganova S, van Steenbergen HW, Verheul MK, Forslind K, Hafstr\u00f6m I, Toes REM et al (2017) The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor. Ann Rheum Dis 76(1):112\u2013118","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"7683_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jbspin.2013.04.004","volume":"81","author":"E Salgado","year":"2014","unstructured":"Salgado E, Maneiro JR, Carmona L, G\u00f3mez-Reino J (2014) Rheumatoid factor and response to TNF antagonists in rheumatoid arthritis: systematic review and meta-analysis of observational studies. Joint Bone Spine 81(1):41\u201350","journal-title":"Joint Bone Spine"},{"issue":"2","key":"7683_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s13317-010-0013-5","volume":"1","author":"M Fabris","year":"2010","unstructured":"Fabris M, De Vita S, Blasone N, Visentini D, Pezzarini E, Pontarini E et al (2010) Serum levels of anti-CCP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab. Autoimmun Highlights 1(2):87\u201394","journal-title":"Autoimmun Highlights"},{"issue":"4","key":"7683_CR10","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/acr.24140","volume":"73","author":"A Zaccardelli","year":"2021","unstructured":"Zaccardelli A, Liu X, Ford JA, Cui J, Lu B, Chu SH et al (2021) Elevated anti-citrullinated protein antibodies prior to rheumatoid arthritis diagnosis and risks for chronic obstructive pulmonary disease or asthma. Arthritis Care Res (Hoboken) 73(4):498\u2013509","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"7683_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21114015","volume":"21","author":"CY Wu","year":"2020","unstructured":"Wu CY, Yang HY, Lai JH (2020) Anti-citrullinated protein antibodies in patients with rheumatoid arthritis: biological effects and mechanisms of immunopathogenesis. Int J Mol Sci 21(11):4015","journal-title":"Int J Mol Sci"},{"issue":"2","key":"7683_CR12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12016-021-08890-1","volume":"63","author":"MV Sokolova","year":"2021","unstructured":"Sokolova MV, Schett G, Steffen U (2021) Autoantibodies in rheumatoid arthritis: historical background and novel findings. Clin Rev Allergy Immunol 63(2):138\u2013151","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"7683_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s13075-015-0736-9","volume":"17","author":"D Aletaha","year":"2015","unstructured":"Aletaha D, Alasti F, Smolen JS (2015) Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials. Arthritis Res Ther 17(1):229","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"7683_CR14","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s00296-015-3271-8","volume":"35","author":"W Katchamart","year":"2015","unstructured":"Katchamart W, Koolvisoot A, Aromdee E, Chiowchanwesawakit P, Muengchan C (2015) Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis. Rheumatol Int 35(10):1693\u20131699","journal-title":"Rheumatol Int"},{"issue":"8","key":"7683_CR15","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/acr.20188","volume":"62","author":"W Katchamart","year":"2010","unstructured":"Katchamart W, Johnson S, Lin HL, Phumethum V, Salliot C, Bombardier C (2010) Predictors for remission in rheumatoid arthritis patients: a systematic review. Arthritis Care Res (Hoboken) 62(8):1128\u20131143","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"7683_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5114\/reum.2018.77976","volume":"56","author":"B Grygiel-G\u00f3rniak","year":"2018","unstructured":"Grygiel-G\u00f3rniak B, Rogacka N, Puszczewicz M (2018) Antinuclear antibodies in healthy people and non-rheumatic diseases \u2013 diagnostic and clinical implications. Rheumatology 56(4):243\u2013248","journal-title":"Rheumatology"},{"issue":"1","key":"7683_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/ard-2022-223356","volume":"82","author":"JS Smolen","year":"2023","unstructured":"Smolen JS, Landew\u00e9 RBM, Bergstra SA, Kerschbaumer A, Sepriano A, Aletaha D et al (2023) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis 82(1):3\u201318","journal-title":"Ann Rheum Dis"},{"key":"7683_CR18","doi-asserted-by":"crossref","unstructured":"Maldonado-Canon K, Verano Castillo D V, Arenas Torrado HF, Coral Alvarado P, Mendez Patarroyo PA, Quintana Lopez G (2021) Triple-positivity and antinuclear antibodies, insights on disease activity: a retrospective cohort study of colombian ra patients. Ann Rheum Dis [Internet]. 80(SUPPL 1):479. Available from: https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L635708062&from=export.\u00a0Accessed 08 Feb 2025","DOI":"10.1136\/annrheumdis-2021-eular.3443"},{"issue":"6","key":"7683_CR19","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/acr2.11271","volume":"3","author":"SS Paknikar","year":"2021","unstructured":"Paknikar SS, Crowson CS, Davis JM, Thanarajasingam U (2021) Exploring the role of antinuclear antibody positivity in the diagnosis, treatment, and health outcomes of patients with rheumatoid arthritis. ACR Open Rheumatol 3(6):422\u2013426","journal-title":"ACR Open Rheumatol"},{"key":"7683_CR20","doi-asserted-by":"crossref","unstructured":"Garcia PM, Ravelli A, Pistorio A, Arguedas O, Murray K, Gerloni V et al (2006) Antinuclear antibody positivity is the best predictor of response to methotrexate in juvenile idiopathic arthritis. Analysis of the printo trial. JCR: J Clin Rheumatol 12(Supplement):S12\u20133","DOI":"10.1097\/01.rhu.0000226492.57829.0c"},{"issue":"3","key":"7683_CR21","first-page":"401","volume":"26","author":"C Gonnet-Gracia","year":"2008","unstructured":"Gonnet-Gracia C, Barnetche T, Richez C, Blanco P, Dehais J, Schaeverbeke T (2008) Anti-nuclear antibodies, anti-DNA and C4 complement evolution in rheumatoid arthritis and ankylosing spondylitis treated with TNF-alpha blockers. Clin Exp Rheumatol 26(3):401\u2013407","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"7683_CR22","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1136\/annrheumdis-2014-205318","volume":"73","author":"K Takase","year":"2014","unstructured":"Takase K, Horton SC, Ganesha A, Das S, McHugh A, Emery P et al (2014) What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort. Ann Rheum Dis 73(9):1695\u20131699","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"7683_CR23","doi-asserted-by":"publisher","first-page":"R213","DOI":"10.1186\/ar3546","volume":"13","author":"N Yukawa","year":"2011","unstructured":"Yukawa N, Fujii T, Kondo-Ishikawa S, Yoshifuji H, Kawabata D, Nojima T et al (2011) Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: a retrospective clinical study. Arthritis Res Ther 13(6):R213","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"7683_CR24","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1002\/art.20617","volume":"50","author":"SJ Bingham","year":"2004","unstructured":"Bingham SJ, Buch MH, Kerr MA, Emery P, Valad\u00e4o Barcelos AT (2004) Induction of antinuclear antibodies in patients with rheumatoid arthritis treated with infliximab and leflunomide. Arthritis Rheum 50(12):4072\u20134073","journal-title":"Arthritis Rheum"},{"issue":"1","key":"7683_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s42358-021-00227-y","volume":"61","author":"G Quintana-L\u00f3pez","year":"2021","unstructured":"Quintana-L\u00f3pez G, Maldonado-Ca\u00f1\u00f3n K, Fl\u00f3rez-Su\u00e1rez JB, M\u00e9ndez-Patarroyo P, Coral-Alvarado P, Calvo E (2021) Correlation and agreement between physical and ultrasound examination after a training session dedicated to the standardization of synovitis assessment in rheumatoid arthritis patients. Adv Rheumatol 61(1):68. https:\/\/doi.org\/10.1186\/s42358-021-00227-y","journal-title":"Adv Rheumatol"},{"issue":"1","key":"7683_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s41927-022-00314-7","volume":"6","author":"K Janke","year":"2022","unstructured":"Janke K, Kiefer C, McGauran N, Richter B, Krause D, Wieseler B (2022) A systematic comparison of different composite measures (DAS 28, CDAI, SDAI, and Boolean approach) for determining treatment effects on low disease activity and remission in rheumatoid arthritis. BMC Rheumatol 6(1):82","journal-title":"BMC Rheumatol"},{"issue":"13","key":"7683_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13133890","volume":"13","author":"F Salehi","year":"2024","unstructured":"Salehi F, Lopera Gonzalez LI, Bayat S, Kleyer A, Zanca D, Brost A et al (2024) Machine learning prediction of treatment response to biological disease-modifying antirheumatic drugs in rheumatoid arthritis. J Clin Med 13(13):3890","journal-title":"J Clin Med"},{"issue":"1","key":"7683_CR28","first-page":"1","volume":"12","author":"KS Durgesh","year":"2010","unstructured":"Durgesh KS, Lekha B (2010) Data classification using support vector machine. J Theor Appl Inf Technol 12(1):1\u20137","journal-title":"J Theor Appl Inf Technol"},{"key":"7683_CR29","unstructured":"Breiman L, Cutler A, Liaw A et al (2018) Package \u2018randomforest.\u2019 University of California, Berkeley, vol 81, pp 1\u201329.\u00a0https:\/\/scholar.google.com\/scholar?hl=es&as_sdt=0%2C5&q=Breiman+L%2C+Cutler+A%2C+Liaw+A%2C+et+al+%282018%29+Package+%E2%80%98randomforest.%E2%80%99+University+of+California%2C+Berkeley%3A+Berkeley&btn"},{"key":"7683_CR30","unstructured":"Zhang L, Zhan C (2017) Machine learning in rock facies classification: an application of XGBoost. In: International Geophysical Conference, Qingdao, China, 17\u201320 April 2017. Society of Exploration Geophysicists and Chinese Petroleum Society,\u00a0pp 1371\u20131374.\u00a0https:\/\/scholar.google.com\/scholar?hl=es&as_sdt=0%2C5&q=Zhang+L%2C+Zhan+C+%282017%29+Machine+learning+in+rock+facies+classification%3A+An+application+of+XGBoost.+In%3A+International+Geophysical+Conference%2C+Q20+April+2017.+Society+of+Exploration+Geophysicists+and+Chinese+Petroleum+Society%2C+pp+1371%E2%80%931374&btnG="},{"key":"7683_CR31","doi-asserted-by":"crossref","unstructured":"Lodha SK, Fitzpatrick DM, Helmbold DP (2007) Aerial lidar data classification using adaboost. In: Sixth International Conference on 3-D Digital Imaging and Modeling (3DIM 2007). IEEE; p 435\u201342.\u00a0https:\/\/scholar.google.com\/scholar?hl=es&as_sdt=0%2C5&q=Fitzpatrick+DM%2C+Helmbold+DP+%282007%29+Aerial+lidar+data+classification+using+adaboost.+In%3A+Sixth+International+Conference+o&btnG=","DOI":"10.1109\/3DIM.2007.10"},{"issue":"2","key":"7683_CR32","doi-asserted-by":"publisher","DOI":"10.4249\/scholarpedia.1883","volume":"4","author":"LE Peterson","year":"2009","unstructured":"Peterson LE (2009) K-nearest neighbor. Scholarpedia 4(2):1883","journal-title":"Scholarpedia"},{"issue":"5","key":"7683_CR33","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/acr.25287","volume":"76","author":"NB Baxter","year":"2024","unstructured":"Baxter NB, Lin C, Wallace BI, Chen J, Kuo C, Chung KC (2024) Development of a machine learning model to predict the use of surgery in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 76(5):636\u2013643","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"7683_CR34","unstructured":"Shapley LS (1953) A value for n-person games.\u00a0https:\/\/scholar.google.com\/scholar?hl=es&as_sdt=0%2C5&q=Shapley+LS+%281953%29+A+value+for+n-person+games&btnG="},{"issue":"1","key":"7683_CR35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40537-020-00327-4","volume":"7","author":"RC Chen","year":"2020","unstructured":"Chen RC, Dewi C, Huang SW, Caraka RE (2020) Selecting critical features for data classification based on machine learning methods. J Big Data 7(1):52","journal-title":"J Big Data"},{"issue":"13","key":"7683_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/app12136681","volume":"12","author":"R Scheda","year":"2022","unstructured":"Scheda R, Diciotti S (2022) Explanations of machine learning models in repeated nested cross-validation: an application in age prediction using brain complexity features. Appl Sci 12(13):6681","journal-title":"Appl Sci"},{"issue":"5","key":"7683_CR37","first-page":"328","volume":"170","author":"RB Dessau","year":"2008","unstructured":"Dessau RB, Pipper CB (2008) R\u2013project for statistical computing. Ugeskr Laeger 170(5):328\u2013330","journal-title":"Ugeskr Laeger"},{"issue":"2","key":"7683_CR38","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.semarthrit.2019.02.003","volume":"49","author":"Y Ishikawa","year":"2019","unstructured":"Ishikawa Y, Hashimoto M, Ito H, Tanaka M, Yukawa N, Fujii T et al (2019) Anti-nuclear antibody development is associated with poor treatment response to biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis. Semin Arthritis Rheum 49(2):204\u2013210","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"7683_CR39","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00296-019-04464-9","volume":"40","author":"K Murata","year":"2020","unstructured":"Murata K, Hashimoto M, Yamamoto W, Son Y, Amuro H, Nagai K et al (2020) The family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patient is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWER cohort study. Rheumatol Int 40(2):217\u2013225","journal-title":"Rheumatol Int"},{"key":"7683_CR40","unstructured":"Maldonado-Ca\u00f1\u00f3n K, Coral-Alvarado P, M\u00e9ndez-Patarroyo P, Bautista-Molano W, Berm\u00fadez E, Quintana-L\u00f3pez G et al (2021) Anti-citrullinated protein antibodies positivity in early RA: insights on disease activity and methotrexate dosage requirements, a cohort study of Colombian RA patients. J Clin Rheumatol [Internet] 27(SUPPL 1):S88\u2013S89. Available from: https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L635754232&from=export.\u00a0Accessed 23 Apr 2025"},{"key":"7683_CR41","doi-asserted-by":"publisher","first-page":"1409555","DOI":"10.3389\/fimmu.2024.1409555","volume":"15","author":"Y Shi","year":"2024","unstructured":"Shi Y, Zhou M, Chang C, Jiang P, Wei K, Zhao J et al (2024) Advancing precision rheumatology: applications of machine learning for rheumatoid arthritis management. Front Immunol 15:1409555","journal-title":"Front Immunol"},{"issue":"11","key":"7683_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0278285","volume":"17","author":"K Dissanayake","year":"2022","unstructured":"Dissanayake K, Jayasinghe C, Wanigasekara P, Dissanayake J, Sominanda A (2022N) Validity of clinical disease activity index (CDAI) to evaluate the disease activity of rheumatoid arthritis patients in Sri Lanka: a prospective follow up study based on newly diagnosed patients. PLoS ONE 17(11):e0278285","journal-title":"PLoS ONE"},{"issue":"2","key":"7683_CR43","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1136\/ard-2023-224742","volume":"83","author":"V Konzett","year":"2024","unstructured":"Konzett V, Kerschbaumer A, Smolen JS, Kristianslund EK, Provan SA, Kvien TK et al (2024) Definition of rheumatoid arthritis flare based on SDAI and CDAI. Ann Rheum Dis 83(2):169\u2013176","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"7683_CR44","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3899\/jrheum.180668","volume":"46","author":"A Luque Ramos","year":"2019","unstructured":"Luque Ramos A, Redeker I, Hoffmann F, Callhoff J, Zink A, Albrecht K (2019) Comorbidities in patients with rheumatoid arthritis and their association with patient-reported outcomes: results of claims data linked to questionnaire survey. J Rheumatol 46(6):564\u2013571","journal-title":"J Rheumatol"},{"issue":"13","key":"7683_CR45","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.2174\/1386207326666230306114626","volume":"26","author":"AH Patil Kose","year":"2023","unstructured":"Patil Kose AH, Mangaonkar K (2023) Application of machine learning in rheumatoid arthritis diseases research: review and future directions. Comb Chem High Throughput Screen 26(13):2259\u20132266","journal-title":"Comb Chem High Throughput Screen"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07683-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07683-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07683-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:15:11Z","timestamp":1762881311000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07683-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["7683"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07683-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"9 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by our institution\u2019s ethics committee (CCEI-12639\u20132020). Written and verbal informed consent for data usage for research purposes was obtained from every patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors declare that there is no conflict of interest regarding the publication of this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}